Industry: Healthcare
Published Date: June-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 219
Report ID: PMRREP34594
1. Executive Summary
1.1. Global Digital Biomarkers Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Supply Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis
4. Price Analysis, 2023A
4.1. Key Highlights
4.2. Key Factors Impacting Therapeutic Area Prices
4.3. Pricing Analysis, By Component
4.4. Regional Prices and Therapeutic Area Preferences
5. Global Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
5.3. Global Digital Biomarkers Market Outlook: Component
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Component, 2018 - 2022
5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
5.3.3.1. Data Collection Tools
5.3.3.1.1. Wearable Devices
5.3.3.1.2. Implantable
5.3.3.1.3. Mobile Applications
5.3.3.1.4. Others
5.3.3.2. Data Integration Software
5.4. Market Attractiveness Analysis: Component
5.5. Global Digital Biomarkers Market Outlook: Therapeutic Area
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By Therapeutic Area, 2018 - 2022
5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
5.5.3.1. Cardiovascular and Metabolic Disorders (CVMD)
5.5.3.2. Neurodegenerative Disorders
5.5.3.3. Diabetes
5.5.3.4. Respiratory Disorders
5.5.3.5. Sleep and Movement Disorders
5.5.3.6. Others
5.6. Market Attractiveness Analysis: Therapeutic Area
5.7. Global Digital Biomarkers Market Outlook: Clinical Practice
5.7.1. Introduction / Key Findings
5.7.2. Historical Market Size (US$ Mn) Analysis, By Clinical Practice, 2018 - 2022
5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
5.7.3.1. Diagnostic Digital Biomarkers
5.7.3.2. Monitoring Digital Biomarkers
5.7.3.3. Predictive and Prognostic Digital Biomarkers
5.7.3.4. Others
5.8. Market Attractiveness Analysis: Clinical Practice
5.9. Global Digital Biomarkers Market Outlook: End User
5.9.1. Introduction / Key Findings
5.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
5.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
5.9.3.1. Healthcare Consumers
5.9.3.2. Healthcare Providers
5.9.3.3. Others
5.10. Market Attractiveness Analysis: End User
6. Global Digital Biomarkers Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Component
7.2.3. By Therapeutic Area
7.2.4. By Clinical Practice
7.2.5. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
7.4.1. Data Collection Tools
7.4.1.1. Wearable Devices
7.4.1.2. Implantable
7.4.1.3. Mobile Applications
7.4.1.4. Others
7.4.2. Data Integration Software
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
7.5.1. Cardiovascular and Metabolic Disorders (CVMD)
7.5.2. Neurodegenerative Disorders
7.5.3. Diabetes
7.5.4. Respiratory Disorders
7.5.5. Sleep and Movement Disorders
7.5.6. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
7.6.1. Diagnostic Digital Biomarkers
7.6.2. Monitoring Digital Biomarkers
7.6.3. Predictive and Prognostic Digital Biomarkers
7.6.4. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
7.7.1. Healthcare Consumers
7.7.2. Healthcare Providers
7.7.3. Others
7.8. Market Attractiveness Analysis
8. Europe Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Component
8.2.3. By Therapeutic Area
8.2.4. By Clinical Practice
8.2.5. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Türkiye
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
8.4.1. Data Collection Tools
8.4.1.1. Wearable Devices
8.4.1.2. Implantable
8.4.1.3. Mobile Applications
8.4.1.4. Others
8.4.2. Data Integration Software
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
8.5.1. Cardiovascular and Metabolic Disorders (CVMD)
8.5.2. Neurodegenerative Disorders
8.5.3. Diabetes
8.5.4. Respiratory Disorders
8.5.5. Sleep and Movement Disorders
8.5.6. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
8.6.1. Diagnostic Digital Biomarkers
8.6.2. Monitoring Digital Biomarkers
8.6.3. Predictive and Prognostic Digital Biomarkers
8.6.4. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
8.7.1. Healthcare Consumers
8.7.2. Healthcare Providers
8.7.3. Others
8.8. Market Attractiveness Analysis
9. East Asia Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Component
9.2.3. By Therapeutic Area
9.2.4. By Clinical Practice
9.2.5. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
9.4.1. Data Collection Tools
9.4.1.1. Wearable Devices
9.4.1.2. Implantable
9.4.1.3. Mobile Applications
9.4.1.4. Others
9.4.2. Data Integration Software
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
9.5.1. Cardiovascular and Metabolic Disorders (CVMD)
9.5.2. Neurodegenerative Disorders
9.5.3. Diabetes
9.5.4. Respiratory Disorders
9.5.5. Sleep and Movement Disorders
9.5.6. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
9.6.1. Diagnostic Digital Biomarkers
9.6.2. Monitoring Digital Biomarkers
9.6.3. Predictive and Prognostic Digital Biomarkers
9.6.4. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
9.7.1. Healthcare Consumers
9.7.2. Healthcare Providers
9.7.3. Others
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Component
10.2.3. By Therapeutic Area
10.2.4. By Clinical Practice
10.2.5. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
10.4.1. Data Collection Tools
10.4.1.1. Wearable Devices
10.4.1.2. Implantable
10.4.1.3. Mobile Applications
10.4.1.4. Others
10.4.2. Data Integration Software
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
10.5.1. Cardiovascular and Metabolic Disorders (CVMD)
10.5.2. Neurodegenerative Disorders
10.5.3. Diabetes
10.5.4. Respiratory Disorders
10.5.5. Sleep and Movement Disorders
10.5.6. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
10.6.1. Diagnostic Digital Biomarkers
10.6.2. Monitoring Digital Biomarkers
10.6.3. Predictive and Prognostic Digital Biomarkers
10.6.4. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
10.7.1. Healthcare Consumers
10.7.2. Healthcare Providers
10.7.3. Others
10.8. Market Attractiveness Analysis
11. Latin America Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Component
11.2.3. By Therapeutic Area
11.2.4. By Clinical Practice
11.2.5. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
11.4.1. Data Collection Tools
11.4.1.1. Wearable Devices
11.4.1.2. Implantable
11.4.1.3. Mobile Applications
11.4.1.4. Others
11.4.2. Data Integration Software
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
11.5.1. Cardiovascular and Metabolic Disorders (CVMD)
11.5.2. Neurodegenerative Disorders
11.5.3. Diabetes
11.5.4. Respiratory Disorders
11.5.5. Sleep and Movement Disorders
11.5.6. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
11.6.1. Diagnostic Digital Biomarkers
11.6.2. Monitoring Digital Biomarkers
11.6.3. Predictive and Prognostic Digital Biomarkers
11.6.4. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
11.7.1. Healthcare Consumers
11.7.2. Healthcare Providers
11.7.3. Others
11.8. Market Attractiveness Analysis
12. Middle East & Africa Digital Biomarkers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
12.2.1. By Country
12.2.2. By Component
12.2.3. By Therapeutic Area
12.2.4. By Clinical Practice
12.2.5. By End User
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Component, 2023 - 2031
12.4.1. Data Collection Tools
12.4.1.1. Wearable Devices
12.4.1.2. Implantable
12.4.1.3. Mobile Applications
12.4.1.4. Others
12.4.2. Data Integration Software
12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031
12.5.1. Cardiovascular and Metabolic Disorders (CVMD)
12.5.2. Neurodegenerative Disorders
12.5.3. Diabetes
12.5.4. Respiratory Disorders
12.5.5. Sleep and Movement Disorders
12.5.6. Others
12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Clinical Practice, 2023 - 2031
12.6.1. Diagnostic Digital Biomarkers
12.6.2. Monitoring Digital Biomarkers
12.6.3. Predictive and Prognostic Digital Biomarkers
12.6.4. Others
12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
12.7.1. Healthcare Consumers
12.7.2. Healthcare Providers
12.7.3. Others
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2023
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. ActiGraph LLC
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. AliveCor Inc.
13.3.2.1. Overview
13.3.2.2. Segments and Products
13.3.2.3. Key Financials
13.3.2.4. Market Developments
13.3.2.5. Market Strategy
13.3.3. Koneksa Health
13.3.3.1. Overview
13.3.3.2. Segments and Products
13.3.3.3. Key Financials
13.3.3.4. Market Developments
13.3.3.5. Market Strategy
13.3.4. Altoida Inc.
13.3.4.1. Overview
13.3.4.2. Segments and Products
13.3.4.3. Key Financials
13.3.4.4. Market Developments
13.3.4.5. Market Strategy
13.3.5. Biogen
13.3.5.1. Overview
13.3.5.2. Segments and Products
13.3.5.3. Key Financials
13.3.5.4. Market Developments
13.3.5.5. Market Strategy
13.3.6. Empatica Inc.
13.3.6.1. Overview
13.3.6.2. Segments and Products
13.3.6.3. Key Financials
13.3.6.4. Market Developments
13.3.6.5. Market Strategy
13.3.7. Vivo Sense
13.3.7.1. Overview
13.3.7.2. Segments and Products
13.3.7.3. Key Financials
13.3.7.4. Market Developments
13.3.7.5. Market Strategy
13.3.8. IXICO plc
13.3.8.1. Overview
13.3.8.2. Segments and Products
13.3.8.3. Key Financials
13.3.8.4. Market Developments
13.3.8.5. Market Strategy
13.3.9. Aural Analytic
13.3.9.1. Overview
13.3.9.2. Segments and Products
13.3.9.3. Key Financials
13.3.9.4. Market Developments
13.3.9.5. Market Strategy
13.3.10. Huma
13.3.10.1. Overview
13.3.10.2. Segments and Products
13.3.10.3. Key Financials
13.3.10.4. Market Developments
13.3.10.5. Market Strategy
13.3.11. Sonde Health, Inc.
13.3.11.1. Overview
13.3.11.2. Segments and Products
13.3.11.3. Key Financials
13.3.11.4. Market Developments
13.3.11.5. Market Strategy
13.3.12. Akili Interactive Labs, Inc.
13.3.12.1. Overview
13.3.12.2. Segments and Products
13.3.12.3. Key Financials
13.3.12.4. Market Developments
13.3.12.5. Market Strategy
13.3.13. Cambridge Cognition Ltd.
13.3.13.1. Overview
13.3.13.2. Segments and Products
13.3.13.3. Key Financials
13.3.13.4. Market Developments
13.3.13.5. Market Strategy
13.3.14. Dassault Systemes (Medidata)
13.3.14.1. Overview
13.3.14.2. Segments and Products
13.3.14.3. Key Financials
13.3.14.4. Market Developments
13.3.14.5. Market Strategy
13.3.15. Shimmer
13.3.15.1. Overview
13.3.15.2. Segments and Products
13.3.15.3. Key Financials
13.3.15.4. Market Developments
13.3.15.5. Market Strategy
13.3.16. Feel Therapeutics
13.3.16.1. Overview
13.3.16.2. Segments and Products
13.3.16.3. Key Financials
13.3.16.4. Market Developments
13.3.16.5. Market Strategy
13.3.17. Clario
13.3.17.1. Overview
13.3.17.2. Segments and Products
13.3.17.3. Key Financials
13.3.17.4. Market Developments
13.3.17.5. Market Strategy
13.3.18. Imagene AI
13.3.18.1. Overview
13.3.18.2. Segments and Products
13.3.18.3. Key Financials
13.3.18.4. Market Developments
13.3.18.5. Market Strategy
13.3.19. Brainomix
13.3.19.1. Overview
13.3.19.2. Segments and Products
13.3.19.3. Key Financials
13.3.19.4. Market Developments
13.3.19.5. Market Strategy
13.3.20. Kinsa Inc.
13.3.20.1. Overview
13.3.20.2. Segments and Products
13.3.20.3. Key Financials
13.3.20.4. Market Developments
13.3.20.5. Market Strategy
13.3.21. Pfizer Hellas S.A.
13.3.21.1. Overview
13.3.21.2. Segments and Products
13.3.21.3. Key Financials
13.3.21.4. Market Developments
13.3.21.5. Market Strategy
13.3.22. Human API
13.3.22.1. Overview
13.3.22.2. Segments and Products
13.3.22.3. Key Financials
13.3.22.4. Market Developments
13.3.22.5. Market Strategy
13.3.23. Evidation Health, Inc.
13.3.23.1. Overview
13.3.23.2. Segments and Products
13.3.23.3. Key Financials
13.3.23.4. Market Developments
13.3.23.5. Market Strategy
13.3.24. Verily
13.3.24.1. Overview
13.3.24.2. Segments and Products
13.3.24.3. Key Financials
13.3.24.4. Market Developments
13.3.24.5. Market Strategy
13.3.25. electronRx
13.3.25.1. Overview
13.3.25.2. Segments and Products
13.3.25.3. Key Financials
13.3.25.4. Market Developments
13.3.25.5. Market Strategy
14. Appendix
4.1. Research Methodology
4.2. Research Assumptions
4.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
